4.8 Article

LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer

Journal

ONCOGENE
Volume 22, Issue 8, Pages 1243-1246

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1206192

Keywords

wild-type Kras2; mutations; lung cancer; loss of heterozygosity; tumor suppressor

Funding

  1. Intramural NIH HHS [ZIA BC010448-09] Funding Source: Medline
  2. NCI NIH HHS [P30 CA016058, R01 CA 58554, P30 CA 16058, R41 CA 093204, R01 CA 78797, R01 CA058554] Funding Source: Medline

Ask authors/readers for more resources

Previous observation has shown that the wild-type Kras2 allele is a suppressor of lung cancer in mice. Here we report that loss of heterozygosity (LOH) of chromosome 12p was detected in similar to50% of human lung adenocarcinomas and large cell carcinomas, and Kras2 mutations were detected at codon 12 in similar to40% of adenocarcinomas and large cell carcinomas. Interestingly, all of the lung adenocarcinomas and large cell carcinomas containing a Kras2 mutation exhibited allelic loss of the wild-type Kras2 allele when a correlation between LOH of the region on chromosome 12p and Kras2 mutation was made. These results from human lung cancer tissues provide a strong evidence in support of our previous observation in mouse models that the wild-type Kras2 is a tumor suppressor of lung cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available